Merck Drops $9.2 Billion to Snag Experimental Flu Drug — A Bold Bet Amid Keytruda Patent Cliff
Merck Makes Massive $9.2 Billion Move to Strengthen Flu Pipeline Merck has just made headlines with a blockbuster acquisition: the
Johnson & Johnson’s Shocking Move: Orthopedics Giant Set to Break Free in Billion-Dollar Spin-Off
J&J Drops Bombshell: Orthopedics Business to Become Independent Company In a stunning development, Johnson & Johnson is preparing to spin